Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
TMDX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$55.00 - $177.37
Previous CloseN/A
Volume1.17M
Average Volume (3M)2.13M
Market Cap
$2.52B
Enterprise Value$5.79B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)85.1
Beta1.59
Next Earnings
Feb 27, 2025EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.93
Shares Outstanding33,561,516
10 Day Avg. Volume1,240,768
30 Day Avg. Volume2,133,829
Standard Deviation0.26
R-Squared0.18
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.65
Price to Cash Flow (P/CF)97.20
P/FCF Ratio0.00
Enterprise Value/Market Cap2.30
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit37.58
Enterprise Value/Ebitda99.59
Forecast
1Y Price Target
$102.38Price Target Upside35.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
---
Bulls Say, Bears Say
Bulls Say
DCD Liver TransplantsDCD liver transplant volumes grew 10.7% quarter over quarter, which could potentially boost Transmedics Group's Q4 results.
Transplant VolumesManagement commentary suggests that TMDX's 2024 transplant volumes exceeded the target of 3,600, indicating a potential beat in consensus revenue for 4Q24.
Bears Say
Heart TransplantsHeart transplants declined 9.9% quarter over quarter, suggesting that Transmedics Group might not meet performance estimates.
---
Ownership Overview
3.32% Insiders
38.52% Mutual Funds
24.14% Other Institutional Investors
8.80% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TMDX FAQ
What was TransMedics Group Inc’s price range in the past 12 months?
TransMedics Group Inc lowest stock price was $55.00 and its highest was $177.37 in the past 12 months.
What is TransMedics Group Inc’s market cap?
TransMedics Group Inc’s market cap is $2.52B.
When is TransMedics Group Inc’s upcoming earnings report date?
TransMedics Group Inc’s upcoming earnings report date is Feb 27, 2025 which is in 5 days.
How were TransMedics Group Inc’s earnings last quarter?
TransMedics Group Inc released its earnings results on Oct 28, 2024. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.293 by -$0.173.
Is TransMedics Group Inc overvalued?
According to Wall Street analysts TransMedics Group Inc’s price is currently Undervalued.
Does TransMedics Group Inc pay dividends?
TransMedics Group Inc does not currently pay dividends.
What is TransMedics Group Inc’s EPS estimate?
TransMedics Group Inc’s EPS estimate is 0.16.
How many shares outstanding does TransMedics Group Inc have?
TransMedics Group Inc has 33,561,516 shares outstanding.
What happened to TransMedics Group Inc’s price movement after its last earnings report?
TransMedics Group Inc reported an EPS of $0.12 in its last earnings report, missing expectations of $0.293. Following the earnings report the stock price went down -29.895%.
Which hedge fund is a major shareholder of TransMedics Group Inc?
Currently, no hedge funds are holding shares in TMDX
---
TransMedics Group Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$102.38 (35.69% Upside)
$102.38 (35.69% Upside)
Blogger Sentiment
Bullish
TMDX Sentiment 94%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 1.7%
Last 30 Days ▼ 1.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.85%
12-Months-Change
Fundamentals
Return on Equity
19.41%
Trailing 12-Months
Asset Growth
13.98%
Trailing 12-Months
Company Description
TransMedics Group Inc
TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.
---
TMDX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with strong year-over-year growth in revenue and logistics services, alongside challenges in sequential revenue decline, gross margin pressure, and operational issues related to aircraft maintenance. The commitment to future growth through next-gen technologies is promising, but short-term challenges remain.Read More>---
TMDX Stock 12 Month Forecast
Average Price Target
$102.38
▲(35.69% Upside)
Technical Analysis
Best Analysts Covering TMDX
1 Year
1 Year Success Rate
17/28 ratings generated profit
1 Year Average Return
+30.24%
reiterated a buy rating 19 days ago
Copying Suraj Kalia's trades and holding each position for 1 Year would result in 60.71% of your transactions generating a profit, with an average return of +30.24% per trade.
---